Hi Stormer, This was in reference to Channel 7 news coverage as...

Hi Stormer,

This was in reference to Channel 7 news coverage as per the ASX ANN today.

NOT Sky Business news. But I’m glad you brought that up. Tony Locantro was talking about another stock prior to DXB and successful cancer trials in dogs.

Being a qualified Veterinary nurse & worked in this industry for 7 years before human nursing, a major health problem & killer in cats is kidney disease, as well as humans. To date I have lost 2 beloved cats to kidney disease between the ages of 15-17 years old & one beautiful dog to osteosarcoma at 14 years old (and due to age & arthritis we decided on palliative treatment for pain management & quality of life). If we had of had more treatment options that weren’t so invasive for an older animal, we gladly would have paid for that. They are part of the family, especially growing up with your children.

I had thought about implications for veterinary treatments for DMX-200, however pharmacokinetics are species specific & you do see a lot of human drugs find their way into animal medicine & vice versa. Tony Locantro’s segment on SKY was good, even though he made a small error about our trial status. It’s not just human based biotechs, veterinary medicine is huge also.